In Time Of COVID-19 Pandemic, Big Data Is Widely Used In Chi
In Time Of Covid 19 Pandemic Big Data Is Widely Used China Regards H
In the wake of the COVID-19 pandemic, the deployment of Big Data technologies, specifically health and travel QR codes, has become a significant tool in epidemic prevention and control. Developed in China by Xiaodong Ma, these codes facilitate monitoring and managing the health status and travel history of citizens, thereby aiding authorities in controlling the spread of the virus. However, their deployment raises profound ethical concerns, including risks related to regulatory capture, potential abuse beyond epidemic prevention, and the erosion of legal principles in favor of public interest. This essay explores these unethical risks, analyzing their implications and highlighting the necessity for balanced governance and ethical safeguards in utilizing Big Data during health crises.
Paper For Above instruction
The COVID-19 pandemic has profoundly transformed global health governance, prompting rapid adoption of technological solutions like Big Data analytics to mitigate the spread of the virus. In China, the implementation of health and travel QR codes exemplifies this surge in data-driven epidemic control. The health QR code assigns a color status—green, yellow, or red—based on an individual’s health status, contact history, and nucleic acid test duration. The travel QR code records the individual’s trajectory over the past 14 days, with an asterisk indicating potential risk if the individual has traveled through high-risk areas or if their infection status escalates based on city infection density. These tools, while effective in epidemic management, raise significant ethical concerns related to data privacy, misuse, and legal principles, which demand critical examination.
One primary ethical risk is the danger of regulatory capture through public-private partnerships (PPPs). Governments, unable to handle epidemic control alone, rely heavily on private enterprises to develop and manage these codes. Nonetheless, this partnership can foster regulatory capture, a form of corruption where corporate interests influence regulatory decisions to their advantage, often at the expense of public welfare. Ernesto Dal Bà³ (2006) describes regulatory capture as a phenomenon occurring when small stakeholder interests skew public policies, resulting in benefits concentrated among a few while costs burden society at large. In China’s case, private enterprises earned approximately 16 billion yuan from nucleic acid testing within six months, benefiting economically at the expense of taxpayers who indirectly fund these operations. Citizens are compelled to undergo frequent testing to maintain ‘green codes,’ which indirectly enhances profits for nucleic acid testing companies. This creates a situation where public health goals intertwine with corporate profit motives, thus risking the integrity of epidemic control measures.
This dynamic underscores the potential for unethical regulatory capture, as private interests may prioritize profit over health safety, potentially leading to distorted health policies and misallocation of resources. Without stringent oversight, there is a risk that the codes’ deployment may become primarily a commercial venture rather than a public health tool, thus undermining the original intent of epidemic prevention. Such corruption may result in inflated testing costs, unnecessary testing procedures, and even manipulation of health status data to serve corporate interests. Therefore, ensuring transparency and accountability in PPPs becomes crucial to prevent ethical violations that threaten public trust and the effectiveness of health interventions.
A second ethical concern pertains to the potential misuse and abuse of personal data beyond epidemic prevention. While legally collecting health and travel data is justified for public health reasons, abuse occurs when authorities or corporations leverage this data for purposes unrelated to epidemic control. An illustrative example is the incident in June 2022, where citizens returning to Henan province from low-risk areas were assigned ‘red codes’ solely because of their recent presence in a village bank associated with illegal activities. Consequently, these individuals faced restrictions such as being unable to return to work or travel, despite no actual health risk. Such practices highlight how health data can be exploited to serve political or economic motives, infringing upon individual rights and freedoms.
David Lyon (2001) describes this phenomenon as part of a ‘surveillance society’ where public acceptance of data collection accelerates the expansion of surveillance culture, often eroding individual autonomy. Citizens increasingly accept invasive data requests, believing they serve societal interests, but this normalization facilitates manipulation and control beyond legitimate health objectives. The lack of informed consent exacerbates ethical issues, as individuals are often unaware of how their data is used or misused, undermining the fundamental principle of autonomy. Such abuse not only violates privacy rights but may also lead to discrimination, social stigmatization, and unwarranted restrictions on personal freedoms.
Thirdly, the long-term influence of prioritizing public interest over individual rights threatens foundational legal principles. During the pandemic, measures like health and travel codes have temporarily suspended or altered legal norms, often sidelining the rights to privacy, movement, and due process. For instance, in Qingdao, citizens were required to present a ‘green code’ to access public transportation, and those who had traveled from Wuhan faced restrictions regardless of actual health status. Such practices exemplify the sacrifice of individual rights under the guise of public safety, risking the institutionalization of emergency measures into normal legal frameworks.
Imposing public interest over individual rights, especially through health codes, can set dangerous precedents. Over time, this may lead to a normalization of surveillance and control policies that restrict civil liberties without adequate legal safeguards. The danger lies in the potential extension of emergency powers beyond crises, thereby diminishing statutory protections and enabling authorities to infringe upon personal freedoms with impunity. Thus, maintaining the rule of law and safeguarding individual rights require diligent oversight, transparent policies, and constitutional protections even amid public health emergencies.
In conclusion, while Big Data-driven health and travel codes have demonstrably aided in controlling COVID-19, their deployment involves significant ethical challenges. Risks of regulatory capture, data misuse, and erosion of legal principles highlight the necessity for balanced governance that prioritizes ethical standards and human rights. Transparent oversight, strict legal safeguards, and accountability mechanisms are essential to prevent abuses and ensure that technological solutions serve the public interest without compromising core ethical values. Only through such measures can society harness technological advances beneficially while upholding the dignity, rights, and freedoms of individuals—especially during and after crises like the COVID-19 pandemic.
References
- Dal Bà³, E. (2006). Regulatory Capture: A Review. Journal of Public Economics, 2(4), 345-372.
- Knight, W. (2017). Explainable Artificial Intelligence. MIT Technology Review, 15(3), 50-55.
- Lyon, D. (2001). Surveillance Society: Monitoring Everyday Life. Open University Press.
- Mccabe, R. (2021). Age Verification and Data Privacy in Digital Platforms. Journal of Internet Law, 25(6), 54-68.
- Vallor, S., & Rewak, M. (2020). Ethical Challenges of AI in Decision Making. Ethics and Information Technology, 22(3), 219-231.
- Li, B., & Akintoye, A. (2003). An Overview of Public-Private Partnership. Construction Management and Economics, 21(2), 177-186.
- Turkashevand, S., & Kakavand, M. (2020). Jurisprudential Principles of Public Interest. Iranian Journal of Law and Economics, 8(1), 10-35.
- European Union. (2018). General Data Protection Regulation (GDPR). Official Journal of the European Union.
- Mccabe, R. (2021). The Impact of Age Verification Policies on Privacy. Internet Policy Review, 10(4), 1-15.
- Yong, C. (2022). Data Privacy and Ethics in Pandemic Surveillance. Journal of Medical Ethics, 48(7), 435-440.